Patented technology that transforms key inflammatory messengers from agents of destruction to agents of repair
Enables you to alter patients’ disease progression and put them on the path to healing
Seamlessly integrates into your critical-care workflow so you won’t miss a beat
Critically ill patients in the throes of a cytokine storm are facing an alarming, urgent situation. That’s because this dangerous, dysregulated hyperinflammatory response can cause multiorgan damage and in severe cases, death.
SeaStar Medical is an innovator with groundbreaking solutions that give you the power to stop this serious threat before it can do irreparable harm to the patients you are fighting for.
Backed by rigorous clinical research and robust scientific evidence, our patented approach is designed to support your clinical end goals including reducing dialysis dependency, improving outcomes, and saving precious lives.
COVID-19, acute respiratory distress syndrome, acute kidney injury, and many other health issues can result in a dangerous cytokine storm. With SeaStar Medical’s novel, simple-to-use SCD immunomodulation technology, you can quickly rescue patients from a cytokine storm, regardless of how it was triggered, and restore reparative functionality to the body and potentially reverse injury.
Representative product illustration; product subject to future changes.
A shorter treatment regimen to reach the desired effect may reduce dependency on dialysis and time in the ICU. This can help put patients on the road back to recovery sooner and free up resources more quickly.
SeaStar Medical is a privately held medical device company that has redefined how extracorporeal therapies may reduce the consequences of excessive inflammation on vital organs through novel solutions and services. SeaStar Medical’s focus is on removing pro-inflammatory mediators, known as cytokines, or transforming key immune system messengers from pro-inflammatory to reparative physiology. SeaStar Medical’s next generation technologies rely on science and innovation to build upon existing purification technologies to provide life-saving solutions to critically ill patients.
©SeaStar Medical 2021